
News|Articles|May 23, 2024
Don’t underestimate the "small stuff"
Author(s)Eurofins BioPharma Product Testing
Learn about the importance of considering human factors testing beyond the initial validation phase. Through two case studies, it illustrates how seemingly minor product changes can trigger regulatory scrutiny. The message is clear: proactive testing and expert guidance are essential to navigate regulatory requirements effectively.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
2
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
3
AAPS PharmSci 360 2025: Trends in Bioanalysis
4
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
5
